Evidence map›Paper›PMID 41876463›Full record

ArticleTranslational psychiatry2026

Prediction of depressive episodes based on clinical features, cognitive characteristics, inflammation-related proteins, and EEG data.

Wenxi Sun, Haidong Yang, Chao Sun, Qing Tian, Peng Chen, Shiting Yuan, Xueying Zhang, Jin Li, Xiaobin Zhang

Abstract read
In one paragraph

Article in Translational psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Wenxi SunSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow University, Suzhou, 215137, Jiangsu Province, China.
Haidong YangDepartment of Psychiatry, The Fourth People's Hospital of Lianyungang, The Affiliated KangDa College of Nanjing Medical University, Lianyungang, 222003, PR China.
Chao SunSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow University, Suzhou, 215137, Jiangsu Province, China.
Qing TianSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow University, Suzhou, 215137, Jiangsu Province, China.ORCID http://orcid.org/0000-0002-3207-6398
Peng ChenSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow University, Suzhou, 215137, Jiangsu Province, China.
Shiting YuanSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow University, Suzhou, 215137, Jiangsu Province, China.
Xueying ZhangSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow University, Suzhou, 215137, Jiangsu Province, China.
Jin LiSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow University, Suzhou, 215137, Jiangsu Province, China.
Xiaobin ZhangSuzhou Guangji Hospital, Suzhou, Jiangsu Province; Affiliated Guangji Hospital of Soochow University, Suzhou, 215137, Jiangsu Province, China. Zhangxiaobim@163.com.ORCID http://orcid.org/0000-0002-0577-5951

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The absence of clinically validated biomarkers and objective diagnostic protocols hinders the accurate and effective diagnosis of depression. Although machine learning has been increasingly explored in psychiatric diagnosis, there remains a pressing need to develop a reliable tool that integrates multimodal data-such as clinical features, cognitive functions, electroencephalographic microstates, and inflammation-associated proteins-to improve diagnostic accuracy and objectivity. One hundred and fifteen patients with depression and 66 healthy controls were included in this study, and data on their clinical characteristics, cognitive function, electroencephalographic microstates, and serum inflammation-related proteins were collected. The baseline depression group was followed up after 4 weeks of clinical treatment, with 56 participants completing the follow-up survey, which mirrored the baseline survey. The depression baseline and healthy control groups were designated as the training set, while the follow-up and healthy control groups served as the validation set. Six classical machine learning algorithms-Decision Tree, Random Forest, XGBoost, LightGBM, k-Nearest Neighbor, and Support Vector Machine-were employed to train the diagnostic prediction model using the training set. The model was then validated with the validation set to identify the optimal depression diagnostic prediction model. The results of the study showed significant differences in clinical characteristics, cognitive function, EEG microstates, and serum levels of inflammation-related proteins in patients with major depressive disorder compared with healthy controls. In the model evaluation, the k-nearest neighbor model performed the best, with an accuracy of 95.08% for multimodal diagnosis, an F1 score of 0.9545, and an AUC value of 0.9969. In order of feature importance were IL-8, IL-18, ISI, MMP-8, CD40, CASP-8, visuospatial/constructional, and mean duration of EEG microstate D. A multimodal, multi-indicator model (incorporating L-8, IL-18, ISI, MMP-8, CD40, CASP-8, visuospatial/constructional abilities, and mean duration of EEG microstate D) has the potential to enhance the accuracy and objectivity of clinical depression diagnoses.

Indexed as

CognitionElectroencephalographyInflammationMajor Depressive DisorderAdultBiomarkersBoosting Machine Learning AlgorithmsCase-Control StudiesClassification AlgorithmsFemaleHumansMachine LearningMaleMiddle AgedPrediction AlgorithmsPredictive Learning ModelsBiomarkers

Identifiers

PMID41876463
PMCPMC13039390

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.